The forecasted import volumes of penicillins or streptomycins in dosage forms to Japan show a gradual upward trend from 2024 to 2028, with an increase each year. In 2023, before these projections, the import value was less, suggesting a consistent growth path. Year-on-Year growth showcases a steady increase pattern, with a 2024 forecasted volume being the reference point for subsequent years.

Trends to watch for in this forecast horizon include:

Technological advancements and innovations in pharmaceutical manufacturing could impact import needs and volumes.
Regulatory changes in Japan's pharmaceutical imports might influence future growth rates.
Environmental and health policies enforcing sustainable practices could affect production and importation dynamics.